{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:21:18Z","timestamp":1761844878322,"version":"3.37.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammation drives the degradation of atherosclerotic plaque, yet there are no non-invasive techniques available for imaging overall inflammation in atherosclerotic plaques, especially in the coronary arteries. To address this, we have developed a clinically relevant system to image overall inflammatory cell burden in plaque. Here, we describe a targeted contrast agent (THI0567-targeted liposomal-Gd) that is suitable for magnetic resonance (MR) imaging and binds with high affinity and selectivity to the integrin \u03b14\u03b21(very late antigen-4, VLA-4), a key integrin involved in recruiting inflammatory cells to atherosclerotic plaques. This liposomal contrast agent has a high T1 relaxivity (~2\u2009\u00d7\u200910<jats:sup>5<\/jats:sup>\u2009mM<jats:sup>\u22121<\/jats:sup>s<jats:sup>\u22121<\/jats:sup>on a particle basis) resulting in the ability to image liposomes at a clinically relevant MR field strength. We were able to visualize atherosclerotic plaques in various regions of the aorta in atherosclerosis-prone ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>mice on a 1 Tesla small animal MRI scanner. These enhanced signals corresponded to the accumulation of monocyte\/macrophages in the subendothelial layer of atherosclerotic plaques<jats:italic>in vivo<\/jats:italic>, whereas non-targeted liposomal nanoparticles did not demonstrate comparable signal enhancement. An inflammatory cell-targeted method that has the specificity and sensitivity to measure the inflammatory burden of a plaque could be used to noninvasively identify patients at risk of an acute ischemic event.<\/jats:p>","DOI":"10.1038\/s41598-018-21893-x","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T15:14:18Z","timestamp":1519226058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin \u03b14\u03b21"],"prefix":"10.1038","volume":"8","author":[{"given":"Darren G.","family":"Woodside","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Tanifum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketan B.","family":"Ghaghada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Biediger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy R.","family":"Caivano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew A.","family":"Starosolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayadeth","family":"Khounlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saakshi","family":"Bhayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrzad","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5679-5629","authenticated-orcid":false,"suffix":"Jr.","given":"John W.","family":"Craft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5926-8501","authenticated-orcid":false,"given":"David S.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandreshkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor V.","family":"Stupin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deenadayalan","family":"Bakthavatsalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert V.","family":"Market","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Willerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A. F.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vanderslice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananth V.","family":"Annapragada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"21893_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","volume":"60","author":"LJ Laslett","year":"2012","unstructured":"Laslett, L. J. et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol 60, S1\u201349, https:\/\/doi.org\/10.1016\/j.jacc.2012.11.002 (2012).","journal-title":"J Am Coll Cardiol"},{"key":"21893_CR2","first-page":"I19","volume":"85","author":"MJ Davies","year":"1992","unstructured":"Davies, M. J. Anatomic features in victims of sudden coronary death. Coronary artery pathology. Circulation 85, I19\u201324 (1992).","journal-title":"Coronary artery pathology. Circulation"},{"key":"21893_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","volume":"34","author":"E Falk","year":"2013","unstructured":"Falk, E., Nakano, M., Bentzon, J. F., Finn, A. V. & Virmani, R. Update on acute coronary syndromes: the pathologists\u2019 view. Eur Heart J 34, 719\u2013728, https:\/\/doi.org\/10.1093\/eurheartj\/ehs411 (2013).","journal-title":"Eur Heart J"},{"key":"21893_CR4","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","volume":"30","author":"AV Finn","year":"2010","unstructured":"Finn, A. V., Nakano, M., Narula, J., Kolodgie, F. D. & Virmani, R. Concept of vulnerable\/unstable plaque. Arterioscler Thromb Vasc Biol 30, 1282\u20131292, https:\/\/doi.org\/10.1161\/ATVBAHA.108.179739 (2010).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"21893_CR5","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","volume":"47","author":"R Virmani","year":"2006","unstructured":"Virmani, R., Burke, A. P., Farb, A. & Kolodgie, F. D. Pathology of the vulnerable plaque. J Am Coll Cardiol 47, C13\u201318, https:\/\/doi.org\/10.1016\/j.jacc.2005.10.065 (2006).","journal-title":"J Am Coll Cardiol"},{"key":"21893_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ahj.2013.02.015","volume":"165","author":"CV Bourantas","year":"2013","unstructured":"Bourantas, C. V., Garcia-Garcia, H. M., Diletti, R., Muramatsu, T. & Serruys, P. W. Early detection and invasive passivation of future culprit lesions: a future potential or an unrealistic pursuit of chimeras? Am Heart J 165, 869\u2013881 e864, https:\/\/doi.org\/10.1016\/j.ahj.2013.02.015 (2013).","journal-title":"Am Heart J"},{"key":"21893_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross, R. Atherosclerosis\u2013an inflammatory disease. N Engl J Med 340, 115\u2013126, https:\/\/doi.org\/10.1056\/NEJM199901143400207 (1999).","journal-title":"N Engl J Med"},{"key":"21893_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature00804","volume":"417","author":"K Skalen","year":"2002","unstructured":"Skalen, K. et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417, 750\u2013754, https:\/\/doi.org\/10.1038\/nature00804 (2002).","journal-title":"Nature"},{"key":"21893_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1126\/science.1990440","volume":"251","author":"MI Cybulsky","year":"1991","unstructured":"Cybulsky, M. I. & Gimbrone, M. A. Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788\u2013791 (1991).","journal-title":"Science"},{"key":"21893_CR10","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1172\/JCI11871","volume":"107","author":"MI Cybulsky","year":"2001","unstructured":"Cybulsky, M. I. et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107, 1255\u20131262, https:\/\/doi.org\/10.1172\/JCI11871 (2001).","journal-title":"J Clin Invest"},{"key":"21893_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/01.CIR.97.1.75","volume":"97","author":"SS Patel","year":"1998","unstructured":"Patel, S. S., Thiagarajan, R., Willerson, J. T. & Yeh, E. T. Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 97, 75\u201381 (1998).","journal-title":"Circulation"},{"key":"21893_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"GK Hansson","year":"2006","unstructured":"Hansson, G. K. & Libby, P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6, 508\u2013519, https:\/\/doi.org\/10.1038\/nri1882 (2006).","journal-title":"Nat Rev Immunol"},{"key":"21893_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/eci.12566","volume":"46","author":"A Pende","year":"2016","unstructured":"Pende, A., Artom, N., Bertolotto, M., Montecucco, F. & Dallegri, F. Role of neutrophils in atherogenesis: an update. Eur J Clin Invest 46, 252\u2013263, https:\/\/doi.org\/10.1111\/eci.12566 (2016).","journal-title":"Eur J Clin Invest"},{"key":"21893_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.med.52.1.289","volume":"52","author":"AE Becker","year":"2001","unstructured":"Becker, A. E., de Boer, O. J. & van Der Wal, A. C. The role of inflammation and infection in coronary artery disease. Annu Rev Med 52, 289\u2013297, https:\/\/doi.org\/10.1146\/annurev.med.52.1.289 (2001).","journal-title":"Annu Rev Med"},{"key":"21893_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/hrt.69.5.377","volume":"69","author":"MJ Davies","year":"1993","unstructured":"Davies, M. J., Richardson, P. D., Woolf, N., Katz, D. R. & Mann, J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69, 377\u2013381 (1993).","journal-title":"Br Heart J"},{"key":"21893_CR16","first-page":"775","volume":"90","author":"PR Moreno","year":"1994","unstructured":"Moreno, P. R. et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90, 775\u2013778 (1994).","journal-title":"Implications for plaque rupture. Circulation"},{"key":"21893_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","volume":"89","author":"AC van der Wal","year":"1994","unstructured":"van der Wal, A. C., Becker, A. E., van der Loos, C. M. & Das, P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36\u201344 (1994).","journal-title":"Circulation"},{"key":"21893_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCRESAHA.117.310694","volume":"121","author":"G Franck","year":"2017","unstructured":"Franck, G. et al. Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion. Circ Res 121, 31\u201342, https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310694 (2017).","journal-title":"Circ Res"},{"key":"21893_CR19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/eurheartj\/ehv044","volume":"36","author":"T Quillard","year":"2015","unstructured":"Quillard, T. et al. TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion. Eur Heart J 36, 1394\u20131404, https:\/\/doi.org\/10.1093\/eurheartj\/ehv044 (2015).","journal-title":"Eur Heart J"},{"key":"21893_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/CIRCRESAHA.112.268144","volume":"111","author":"T Quillard","year":"2012","unstructured":"Quillard, T. & Libby, P. Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. Circ Res 111, 231\u2013244, https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.268144 (2012).","journal-title":"Circ Res"},{"key":"21893_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1161\/ATVBAHA.108.165563","volume":"29","author":"JH Rudd","year":"2009","unstructured":"Rudd, J. H., Hyafil, F. & Fayad, Z. A. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol 29, 1009\u20131016, https:\/\/doi.org\/10.1161\/ATVBAHA.108.165563 (2009).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"21893_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00259-002-1018-8","volume":"30","author":"JT Deichen","year":"2003","unstructured":"Deichen, J. T., Prante, O., Gack, M., Schmiedehausen, K. & Kuwert, T. Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 30, 267\u2013273, https:\/\/doi.org\/10.1007\/s00259-002-1018-8 (2003).","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"21893_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14064","volume":"8","author":"EJ Keliher","year":"2017","unstructured":"Keliher, E. J. et al. Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease. Nat Commun 8, 14064, https:\/\/doi.org\/10.1038\/ncomms14064 (2017).","journal-title":"Nat Commun"},{"key":"21893_CR24","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","volume":"69","author":"JM Tarkin","year":"2017","unstructured":"Tarkin, J. M. et al. Detection of Atherosclerotic Inflammation by (68)Ga-DOTATATE PET Compared to [(18)F]FDG PET Imaging. J Am Coll Cardiol 69, 1774\u20131791, https:\/\/doi.org\/10.1016\/j.jacc.2017.01.060 (2017).","journal-title":"J Am Coll Cardiol"},{"key":"21893_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCRESAHA.116.307971","volume":"119","author":"MR Dweck","year":"2016","unstructured":"Dweck, M. R. et al. Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis. Circ Res 119, 330\u2013340, https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307971 (2016).","journal-title":"Circ Res"},{"key":"21893_CR26","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.2174\/1381612821666150915104529","volume":"21","author":"SM Kazuma","year":"2015","unstructured":"Kazuma, S. M. et al. Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis. Curr Pharm Des 21, 5267\u20135276 (2015).","journal-title":"Curr Pharm Des"},{"key":"21893_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s00330-015-3881-2","volume":"26","author":"D Norenberg","year":"2016","unstructured":"Norenberg, D. et al. Molecular magnetic resonance imaging of atherosclerotic vessel wall disease. Eur Radiol 26, 910\u2013920, https:\/\/doi.org\/10.1007\/s00330-015-3881-2 (2016).","journal-title":"Eur Radiol"},{"key":"21893_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/HCO.0000000000000226","volume":"30","author":"EA Osborn","year":"2015","unstructured":"Osborn, E. A. & Jaffer, F. A. Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets. Curr Opin Cardiol 30, 671\u2013680, https:\/\/doi.org\/10.1097\/HCO.0000000000000226 (2015).","journal-title":"Curr Opin Cardiol"},{"key":"21893_CR29","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2217\/nnm.15.26","volume":"10","author":"RU Palekar","year":"2015","unstructured":"Palekar, R. U., Jallouk, A. P., Lanza, G. M., Pan, H. & Wickline, S. A. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents. Nanomedicine (Lond) 10, 1817\u20131832, https:\/\/doi.org\/10.2217\/nnm.15.26 (2015).","journal-title":"Nanomedicine (Lond)"},{"key":"21893_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.addr.2016.09.005","volume":"113","author":"C Reimann","year":"2017","unstructured":"Reimann, C. et al. Molecular imaging of the extracellular matrix in the context of atherosclerosis. Adv Drug Deliv Rev 113, 49\u201360, https:\/\/doi.org\/10.1016\/j.addr.2016.09.005 (2017).","journal-title":"Adv Drug Deliv Rev"},{"key":"21893_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12410-011-9114-4","volume":"5","author":"BC Te Boekhorst","year":"2012","unstructured":"Te Boekhorst, B. C., van Tilborg, G. A., Strijkers, G. J. & Nicolay, K. Molecular MRI of Inflammation in Atherosclerosis. Curr Cardiovasc Imaging Rep 5, 60\u201368, https:\/\/doi.org\/10.1007\/s12410-011-9114-4 (2012).","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"21893_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2967\/jnumed.116.179663","volume":"58","author":"F Hyafil","year":"2017","unstructured":"Hyafil, F. et al. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer (68)Ga-Pentixafor for PET. J Nucl Med 58, 499\u2013506, https:\/\/doi.org\/10.2967\/jnumed.116.179663 (2017).","journal-title":"J Nucl Med"},{"key":"21893_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2967\/jnumed.115.155176","volume":"56","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques. J Nucl Med 56, 939\u2013944, https:\/\/doi.org\/10.2967\/jnumed.115.155176 (2015).","journal-title":"J Nucl Med"},{"key":"21893_CR34","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1021\/acsomega.6b00210","volume":"1","author":"SP Yoo","year":"2016","unstructured":"Yoo, S. P. et al. Gadolinium-functionalized peptide amphiphile micelles for multimodal imaging of atherosclerotic lesions. ACS Omega 1, 996\u20131003, https:\/\/doi.org\/10.1021\/acsomega.6b00210 (2016).","journal-title":"ACS Omega"},{"key":"21893_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jacc.2010.09.023","volume":"57","author":"KC Briley-Saebo","year":"2011","unstructured":"Briley-Saebo, K. C. et al. Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. J Am Coll Cardiol 57, 337\u2013347, https:\/\/doi.org\/10.1016\/j.jacc.2010.09.023 (2011).","journal-title":"J Am Coll Cardiol"},{"key":"21893_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biomaterials.2015.02.088","volume":"53","author":"S Meier","year":"2015","unstructured":"Meier, S. et al. Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis. Biomaterials 53, 137\u2013148, https:\/\/doi.org\/10.1016\/j.biomaterials.2015.02.088 (2015).","journal-title":"Biomaterials"},{"key":"21893_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.atherosclerosis.2016.09.005","volume":"254","author":"C Liu","year":"2016","unstructured":"Liu, C. et al. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment. Atherosclerosis 254, 263\u2013270, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.09.005 (2016).","journal-title":"Atherosclerosis"},{"key":"21893_CR38","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/CIRCRESAHA.112.265140","volume":"110","author":"A Broisat","year":"2012","unstructured":"Broisat, A. et al. Nanobodies targeting mouse\/human VCAM1 for the nuclear imaging of atherosclerotic lesions. Circ Res 110, 927\u2013937, https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.265140 (2012).","journal-title":"Circ Res"},{"key":"21893_CR39","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1016\/S0021-9258(18)60831-2","volume":"262","author":"ME Hemler","year":"1987","unstructured":"Hemler, M. E. et al. Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem 262, 11478\u201311485 (1987).","journal-title":"J Biol Chem"},{"key":"21893_CR40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1096\/fasebj.9.11.7544310","volume":"9","author":"P Kubes","year":"1995","unstructured":"Kubes, P. et al. A novel beta 1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J 9, 1103\u20131111 (1995).","journal-title":"FASEB J"},{"key":"21893_CR41","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman, C. H. et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354, 899\u2013910, https:\/\/doi.org\/10.1056\/NEJMoa044397 (2006).","journal-title":"N Engl J Med"},{"key":"21893_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pupt.2003.10.004","volume":"17","author":"P Vanderslice","year":"2004","unstructured":"Vanderslice, P. et al. Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD. Pulm Pharmacol Ther 17, 1\u201310, https:\/\/doi.org\/10.1016\/j.pupt.2003.10.004 (2004).","journal-title":"Pulm Pharmacol Ther"},{"key":"21893_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/00063030-200822020-00002","volume":"22","author":"DG Woodside","year":"2008","unstructured":"Woodside, D. G. & Vanderslice, P. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease. BioDrugs 22, 85\u2013100 (2008).","journal-title":"BioDrugs"},{"key":"21893_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-med-042513-125551","volume":"66","author":"A Annapragada","year":"2015","unstructured":"Annapragada, A. Advances in nanoparticle imaging technology for vascular pathologies. Annu Rev Med 66, 177\u2013193, https:\/\/doi.org\/10.1146\/annurev-med-042513-125551 (2015).","journal-title":"Annu Rev Med"},{"key":"21893_CR45","first-page":"448","volume":"194","author":"RJ Biediger","year":"2001","unstructured":"Biediger, R. J. et al. N,N-disubstituted amides that inhibit the binding of integrins to their receptors, US 6,194,448. US patent U. S. Patent No. 6 194, 448 (2001).","journal-title":"US patent U. S. Patent No. 6"},{"key":"21893_CR46","first-page":"296","volume":"972","author":"RJCQ Biediger","year":"2005","unstructured":"Biediger, R. J. C. Q. et al. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors. U.S. patent Patent No. 6 972, 296 (2005).","journal-title":"U.S. patent Patent No. 6"},{"key":"21893_CR47","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.158.4.1710","volume":"158","author":"P Vanderslice","year":"1997","unstructured":"Vanderslice, P. et al. A cyclic hexapeptide is a potent antagonist of alpha 4 integrins. J Immunol 158, 1710\u20131718 (1997).","journal-title":"J Immunol"},{"key":"21893_CR48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbrc.2010.08.114","volume":"400","author":"P Vanderslice","year":"2010","unstructured":"Vanderslice, P. et al. Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin alpha4beta1. Biochem Biophys Res Commun 400, 619\u2013624, https:\/\/doi.org\/10.1016\/j.bbrc.2010.08.114 (2010).","journal-title":"Biochem Biophys Res Commun"},{"key":"21893_CR49","doi-asserted-by":"publisher","first-page":"7826","DOI":"10.1073\/pnas.1219888110","volume":"110","author":"N Kawasaki","year":"2013","unstructured":"Kawasaki, N. et al. Targeted delivery of lipid antigen to macrophages via the CD169\/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation. Proc Natl Acad Sci USA 110, 7826\u20137831, https:\/\/doi.org\/10.1073\/pnas.1219888110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"21893_CR50","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/bit.24340","volume":"109","author":"N Zhang","year":"2012","unstructured":"Zhang, N. & Palmer, A. F. Liposomes surface conjugated with human hemoglobin target delivery to macrophages. Biotechnol Bioeng 109, 823\u2013829, https:\/\/doi.org\/10.1002\/bit.24340 (2012).","journal-title":"Biotechnol Bioeng"},{"key":"21893_CR51","doi-asserted-by":"publisher","first-page":"e7628","DOI":"10.1371\/journal.pone.0007628","volume":"4","author":"KB Ghaghada","year":"2009","unstructured":"Ghaghada, K. B. et al. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One 4, e7628, https:\/\/doi.org\/10.1371\/journal.pone.0007628 (2009).","journal-title":"PLoS One"},{"key":"21893_CR52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4049\/jimmunol.147.2.398","volume":"147","author":"BM Chan","year":"1991","unstructured":"Chan, B. M., Wong, J. G., Rao, A. & Hemler, M. E. T cell receptor-dependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix. J Immunol 147, 398\u2013404 (1991).","journal-title":"J Immunol"},{"key":"21893_CR53","doi-asserted-by":"publisher","first-page":"32704","DOI":"10.1074\/jbc.M802066200","volume":"283","author":"D Valdramidou","year":"2008","unstructured":"Valdramidou, D., Humphries, M. J. & Mould, A. P. Distinct roles of beta1 metal ion-dependent adhesion site (MIDAS), adjacent to MIDAS (ADMIDAS), and ligand-associated metal-binding site (LIMBS) cation-binding sites in ligand recognition by integrin alpha2beta1. J Biol Chem 283, 32704\u201332714, https:\/\/doi.org\/10.1074\/jbc.M802066200 (2008).","journal-title":"J Biol Chem"},{"key":"21893_CR54","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.4049\/jimmunol.167.5.2824","volume":"167","author":"DM Rose","year":"2001","unstructured":"Rose, D. M., Grabovsky, V., Alon, R. & Ginsberg, M. H. The affinity of integrin alpha(4)beta(1) governs lymphocyte migration. J Immunol 167, 2824\u20132830 (2001).","journal-title":"J Immunol"},{"key":"21893_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","volume":"14","author":"Y Nakashima","year":"1994","unstructured":"Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L. & Ross, R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14, 133\u2013140 (1994).","journal-title":"Arterioscler Thromb"},{"key":"21893_CR56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jcmg.2012.06.016","volume":"6","author":"W Chen","year":"2013","unstructured":"Chen, W. et al. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression. JACC Cardiovasc Imaging 6, 373\u2013384, https:\/\/doi.org\/10.1016\/j.jcmg.2012.06.016 (2013).","journal-title":"JACC Cardiovasc Imaging"},{"key":"21893_CR57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/14779072.2017.1297231","volume":"15","author":"K Patel","year":"2017","unstructured":"Patel, K. et al. Invasive or non-invasive imaging for detecting high-risk coronary lesions? Expert Rev Cardiovasc Ther 15, 165\u2013179, https:\/\/doi.org\/10.1080\/14779072.2017.1297231 (2017).","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"21893_CR58","doi-asserted-by":"crossref","unstructured":"Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673\u2013687, https:\/\/doi:S0092867402009716 (2002).","DOI":"10.1016\/S0092-8674(02)00971-6"},{"key":"21893_CR59","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nrd3266","volume":"9","author":"D Cox","year":"2010","unstructured":"Cox, D., Brennan, M. & Moran, N. Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov 9, 804\u2013820, https:\/\/doi.org\/10.1038\/nrd3266 (2010).","journal-title":"Nat Rev Drug Discov"},{"key":"21893_CR60","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrd1174","volume":"2","author":"M Shimaoka","year":"2003","unstructured":"Shimaoka, M. & Springer, T. A. Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov 2, 703\u2013716, https:\/\/doi.org\/10.1038\/nrd1174 (2003).","journal-title":"Nat Rev Drug Discov"},{"key":"21893_CR61","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1517\/13543784.15.10.1235","volume":"15","author":"P Vanderslice","year":"2006","unstructured":"Vanderslice, P. & Woodside, D. G. Integrin antagonists as therapeutics for inflammatory diseases. Expert Opin Investig Drugs 15, 1235\u20131255, https:\/\/doi.org\/10.1517\/13543784.15.10.1235 (2006).","journal-title":"Expert Opin Investig Drugs"},{"key":"21893_CR62","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nsmb.3161","volume":"23","author":"N De Franceschi","year":"2016","unstructured":"De Franceschi, N. et al. Selective integrin endocytosis is driven by interactions between the integrin alpha-chain and AP2. Nat Struct Mol Biol 23, 172\u2013179, https:\/\/doi.org\/10.1038\/nsmb.3161 (2016).","journal-title":"Nat Struct Mol Biol"},{"key":"21893_CR63","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1161\/01.CIR.0000093185.16083.95","volume":"108","author":"PM Winter","year":"2003","unstructured":"Winter, P. M. et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 108, 2270\u20132274, https:\/\/doi.org\/10.1161\/01.CIR.0000093185.16083.95 (2003).","journal-title":"Circulation"},{"key":"21893_CR64","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/RLI.0b013e31821e62fb","volume":"46","author":"D Duerschmied","year":"2011","unstructured":"Duerschmied, D. et al. Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis. Invest Radiol 46, 618\u2013623, https:\/\/doi.org\/10.1097\/RLI.0b013e31821e62fb (2011).","journal-title":"Invest Radiol"},{"key":"21893_CR65","doi-asserted-by":"publisher","first-page":"13167","DOI":"10.1074\/jbc.274.19.13167","volume":"274","author":"LL Chen","year":"1999","unstructured":"Chen, L. L., Whitty, A., Lobb, R. R., Adams, S. P. & Pepinsky, R. B. Multiple activation states of integrin alpha4beta1 detected through their different affinities for a small molecule ligand. J Biol Chem 274, 13167\u201313175 (1999).","journal-title":"J Biol Chem"},{"key":"21893_CR66","doi-asserted-by":"crossref","unstructured":"Liu, S., Rose, D. M., Han, J. & Ginsberg, M. H. Alpha4 integrins in cardiovascular development and diseases. Trends Cardiovasc Med 10, 253\u2013257, https:\/\/doi:S1050-1738(00)00073-6 (2000).","DOI":"10.1016\/S1050-1738(00)00073-6"},{"key":"21893_CR67","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1189\/jlb.1009704","volume":"88","author":"A Mambole","year":"2010","unstructured":"Mambole, A., Bigot, S., Baruch, D., Lesavre, P. & Halbwachs-Mecarelli, L. Human neutrophil integrin alpha9beta1: up-regulation by cell activation and synergy with beta2 integrins during adhesion to endothelium under flow. J Leukoc Biol 88, 321\u2013327, https:\/\/doi.org\/10.1189\/jlb.1009704 (2010).","journal-title":"J Leukoc Biol"},{"key":"21893_CR68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jconrel.2006.05.028","volume":"114","author":"JM Saul","year":"2006","unstructured":"Saul, J. M., Annapragada, A. V. & Bellamkonda, R. V. A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release 114, 277\u2013287, https:\/\/doi.org\/10.1016\/j.jconrel.2006.05.028 (2006).","journal-title":"J Control Release"},{"key":"21893_CR69","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.immuni.2006.10.013","volume":"25","author":"C Chen","year":"2006","unstructured":"Chen, C. et al. The Integrin alpha9beta1 contributes to granulopoiesis by enhancing granulocyte colony-stimulating factor receptor signaling. Immunity 25, 895\u2013906, https:\/\/doi.org\/10.1016\/j.immuni.2006.10.013 (2006).","journal-title":"Immunity"},{"key":"21893_CR70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/01.RES.80.2.159","volume":"80","author":"C Duplaa","year":"1997","unstructured":"Duplaa, C. et al. The integrin very late antigen-4 is expressed in human smooth muscle cell. Involvement of alpha 4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation. Circ Res 80, 159\u2013169 (1997).","journal-title":"Circ Res"},{"key":"21893_CR71","doi-asserted-by":"crossref","first-page":"14019","DOI":"10.1016\/S0021-9258(19)49672-5","volume":"267","author":"SP Massia","year":"1992","unstructured":"Massia, S. P. & Hubbell, J. A. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin alpha 4 beta 1. J Biol Chem 267, 14019\u201314026 (1992).","journal-title":"J Biol Chem"},{"key":"21893_CR72","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/A:1009296700991","volume":"2","author":"P Vanderslice","year":"1998","unstructured":"Vanderslice, P. et al. Angiogenesis induced by tumor necrosis factor-agr; is mediated by alpha4 integrins. Angiogenesis 2, 265\u2013275 (1998).","journal-title":"Angiogenesis"},{"key":"21893_CR73","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.jacc.2015.02.034","volume":"65","author":"M Nahrendorf","year":"2015","unstructured":"Nahrendorf, M. et al. Imaging systemic inflammatory networks in ischemic heart disease. J Am Coll Cardiol 65, 1583\u20131591, https:\/\/doi.org\/10.1016\/j.jacc.2015.02.034 (2015).","journal-title":"J Am Coll Cardiol"},{"key":"21893_CR74","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1021\/ar800192p","volume":"42","author":"S Aime","year":"2009","unstructured":"Aime, S., Castelli, D. D., Crich, S. G., Gianolio, E. & Terreno, E. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res 42, 822\u2013831, https:\/\/doi.org\/10.1021\/ar800192p (2009).","journal-title":"Acc Chem Res"},{"key":"21893_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/cmmi.267","volume":"4","author":"P Caravan","year":"2009","unstructured":"Caravan, P., Farrar, C. T., Frullano, L. & Uppal, R. Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imaging 4, 89\u2013100, https:\/\/doi.org\/10.1002\/cmmi.267 (2009).","journal-title":"Contrast Media Mol Imaging"},{"key":"21893_CR76","doi-asserted-by":"publisher","unstructured":"Tanifum, E. A. et al. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. J Alzheimers Dis 52, 731\u2013745, https:\/\/doi.org\/10.3233\/JAD-151124 (2016).","DOI":"10.3233\/JAD-151124"},{"key":"21893_CR77","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1076-6332(03)80055-7","volume":"10","author":"CY Kao","year":"2003","unstructured":"Kao, C. Y., Hoffman, E. A., Beck, K. C., Bellamkonda, R. V. & Annapragada, A. V. Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging. Acad Radiol 10, 475\u2013483 (2003).","journal-title":"Acad Radiol"},{"key":"21893_CR78","doi-asserted-by":"publisher","first-page":"298","DOI":"10.18632\/oncotarget.261","volume":"2","author":"AP Mann","year":"2011","unstructured":"Mann, A. P. et al. Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget 2, 298\u2013304, https:\/\/doi.org\/10.18632\/oncotarget.261 (2011).","journal-title":"Oncotarget"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21893-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:02:40Z","timestamp":1693548160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21893-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21893"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21893-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"2 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.G.W., R.J.B., R.V.M., P.V., R.A.F.D., J.T.W., A.A., and E.A.T. are inventors on patent application number 62\/491,349 (Title: Targeting Nanoparticles) filed by the Texas Heart Institute and the Texas Children\u2019s Hospital, based in part, on the results presented here.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3733"}}